Published in Thromb Haemost on September 26, 2012
Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids (2015) 0.95
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc (2014) 0.93
The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int J Mol Sci (2014) 0.86
Association of MicroRNAs and YRNAs With Platelet Function. Circ Res (2015) 0.84
Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol (2015) 0.80
Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction. Arch Med Sci (2016) 0.80
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. J Am Heart Assoc (2014) 0.80
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy. Haematologica (2014) 0.77
Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous disease. J Am Heart Assoc (2014) 0.77
Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment. Biomed Res Int (2016) 0.75
Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis? Med Sci Monit (2016) 0.75
Quantitative genetics of circulating Dickkopf-related protein 1 (DKK1) in community-based sample of UK twins. Osteoporos Int (2016) 0.75
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol (2009) 2.11
Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis (2008) 1.96
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med (2007) 1.88
Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med (2007) 1.67
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J (2008) 1.66
Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev (2010) 1.60
Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial. Circ Cardiovasc Interv (2012) 1.54
"Proteomineering" or not? The debate on biomarker discovery in sera continues. J Proteomics (2011) 1.50
VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension. Clin Biochem (2010) 1.48
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol (2003) 1.39
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. Circ J (2015) 1.39
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res (2012) 1.38
Soluble forms of RAGE in internal medicine. Intern Emerg Med (2009) 1.28
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab (2003) 1.22
Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. Mol Biol Cell (2003) 1.19
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem (2009) 1.18
Soluble CD40 ligand plasma levels in lung cancer. Clin Cancer Res (2004) 1.15
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol (2004) 1.15
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics (2012) 1.11
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation (2002) 1.09
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. Int J Colorectal Dis (2010) 1.07
Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta (2008) 1.06
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol (2013) 1.05
Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank (2012) 1.05
Diabetes mellitus and thrombosis. Thromb Res (2011) 1.04
Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol (2006) 1.00
Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep (2004) 0.98
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost (2010) 0.98
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood (2005) 0.98
Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res (2007) 0.97
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol (2005) 0.97
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J (2009) 0.97
Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res (2009) 0.96
Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. J Mol Diagn (2012) 0.95
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM). Neurol Sci (2013) 0.95
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence. Int J Cancer (2013) 0.94
Impact of preanalytical handling and timing for peripheral blood mononuclear cells isolation and RNA studies: the experience of the Interinstitutional Multidisciplinary BioBank (BioBIM). Int J Biol Markers (2012) 0.94
Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest (2002) 0.94
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J (2010) 0.93
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer. Thromb Res (2009) 0.92
Genetic instability in superficial bladder cancer and adjacent mucosa: an interphase cytogenetic study. Hum Pathol (2003) 0.92
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production. Thromb Haemost (2003) 0.91
Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma. Cancer Lett (2005) 0.91
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study. Pharmacogenomics (2014) 0.89
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J Immunol Methods (2012) 0.89
Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case. Surg Today (2009) 0.88
Prion protein gene M129V polymorphism and variability in age at migraine onset. Headache (2013) 0.88
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol (2005) 0.88
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal (2012) 0.88
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. J Infect (2008) 0.88
Association between Birt Hogg Dube syndrome and cancer predisposition. Anticancer Res (2010) 0.87
Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer. Cancer Res (2002) 0.87
Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine. DNA Cell Biol (2014) 0.87
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers. Thromb Haemost (2003) 0.87
Prognostic value of soluble P-selectin levels in colorectal cancer. Int J Cancer (2004) 0.86
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Clin Biochem (2010) 0.86
Thromboembolic events in patients treated with anti-angiogenic drugs. Curr Vasc Pharmacol (2010) 0.86
Functional impairment in video terminal operators is related to low-grade inflammation. Int Arch Occup Environ Health (2010) 0.86
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients. Clin Lung Cancer (2012) 0.85
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors. Pharmacogenomics (2014) 0.85
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study. J Headache Pain (2015) 0.85
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. Atherosclerosis (2010) 0.85
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood (2008) 0.85
Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype? Antioxid Redox Signal (2014) 0.84
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B). Med Oncol (2013) 0.84
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer (2014) 0.84
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke (2005) 0.84
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome. Anticancer Res (2014) 0.84
Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol (2005) 0.84
Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning. Pharmacogenomics (2012) 0.84
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev (2008) 0.83
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic Biol Med (2012) 0.83
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. J Am Heart Assoc (2013) 0.83
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. Intern Emerg Med (2010) 0.83
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer. Oncology (2007) 0.83
Birt-Hogg-Dubé (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene. Eur J Dermatol (2008) 0.83
Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging (2006) 0.83
Preanalytical Procedures for DNA Studies: The Experience of the Interinstitutional Multidisciplinary BioBank (BioBIM). Biopreserv Biobank (2011) 0.83
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer. Int J Colorectal Dis (2012) 0.83
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci (Lond) (2008) 0.82
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. Thromb Haemost (2009) 0.82
Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. Oncology (2003) 0.82